Tri Locum Partners’s Cano Health, Inc. CANO Stock Holding History

Tri Locum Partners’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,415	Closed	-$1.26M	–	58
2021 Q4	$1.26M	Buy	+1,415	New	+$1.49M	0.5%	33

Other funds holding CANO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Tri Locum Partners's CANO Position: Q1 2022 in Review

Tri Locum Partners sold out of Cano Health, Inc. (CANO) in Q1 2022, closing a stake of 1,415 shares — an estimated $1.26M sold.

Tri Locum Partners first reported a position in CANO in Q4 2021 and held it in 1 quarter. The position peaked at $1.26M in Q4 2021. 146 funds tracked by Wall St. Rank hold CANO as of Q1 2022.

Tri Locum Partners reported no remaining Cano Health, Inc. position as of Q1 2022 after selling out during the quarter.
Tri Locum Partners sold 1,415 Cano Health, Inc. shares in Q1 2022, an estimated $1.26M.
Tri Locum Partners first reported a position in Cano Health, Inc. in Q4 2021 and held it in 1 quarter.
Tri Locum Partners's Cano Health, Inc. position peaked at $1.26M in Q4 2021.
146 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2022.

Based on Tri Locum Partners's 13F filing for Q1 2022, filed 16 May 2022.